Decreased expression of cd44 in metastat
β
Marinus A. Noordzij; Gert Jan van Steenbrugge; Fritz H. SchrΓΆder; Theodorus H. V
π
Article
π
1999
π
John Wiley and Sons
π
French
β 558 KB
Decreased expression of CD44 is an independent prognostic marker for surgically treated prostate cancer. To investigate immunohistochemically defined CD44 expression in primary and metastatic prostate cancer, 2 groups of patients undergoing radical prostatectomy for clinically localized prostate can